JP2006507229A5 - - Google Patents

Download PDF

Info

Publication number
JP2006507229A5
JP2006507229A5 JP2004519705A JP2004519705A JP2006507229A5 JP 2006507229 A5 JP2006507229 A5 JP 2006507229A5 JP 2004519705 A JP2004519705 A JP 2004519705A JP 2004519705 A JP2004519705 A JP 2004519705A JP 2006507229 A5 JP2006507229 A5 JP 2006507229A5
Authority
JP
Japan
Prior art keywords
gly
asp
dimer
pro
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004519705A
Other languages
English (en)
Japanese (ja)
Other versions
JP4668612B2 (ja
JP2006507229A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/020626 external-priority patent/WO2004005317A2/en
Publication of JP2006507229A publication Critical patent/JP2006507229A/ja
Publication of JP2006507229A5 publication Critical patent/JP2006507229A5/ja
Application granted granted Critical
Publication of JP4668612B2 publication Critical patent/JP4668612B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004519705A 2002-07-02 2003-07-01 トロンビンペプチド誘導体ダイマー Expired - Fee Related JP4668612B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39357902P 2002-07-02 2002-07-02
PCT/US2003/020626 WO2004005317A2 (en) 2002-07-02 2003-07-01 Thrombin peptide derivative dimers

Publications (3)

Publication Number Publication Date
JP2006507229A JP2006507229A (ja) 2006-03-02
JP2006507229A5 true JP2006507229A5 (enExample) 2006-08-17
JP4668612B2 JP4668612B2 (ja) 2011-04-13

Family

ID=30115603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004519705A Expired - Fee Related JP4668612B2 (ja) 2002-07-02 2003-07-01 トロンビンペプチド誘導体ダイマー

Country Status (8)

Country Link
US (2) US7456250B2 (enExample)
EP (1) EP1539800B1 (enExample)
JP (1) JP4668612B2 (enExample)
AT (1) ATE362939T1 (enExample)
AU (1) AU2003247848B2 (enExample)
CA (1) CA2491135A1 (enExample)
DE (1) DE60313982T2 (enExample)
WO (1) WO2004005317A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551525C (en) * 2003-12-31 2013-02-19 David W. Hobson Pharmaceutical composition for thrombin peptide derivatives
WO2008036387A2 (en) * 2006-09-22 2008-03-27 Orthologic Corp. Method of treating endothelial dysfunction
WO2008100567A2 (en) * 2007-02-15 2008-08-21 Orthologic Corp. Thrombin peptide derivatives for treating fractures in osteopenic patients
WO2008124172A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for chronic dermal ulcers
WO2008124173A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for cardiac revascularization and cardiac repair
WO2009120304A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
AU2009229395A1 (en) * 2008-03-26 2009-10-01 The Board Of Regents, The University Of Texas System Method of treating degenerative diseases
WO2009120307A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
CU23716A1 (es) * 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech Péptido antagonista de la actividad de la interleucina-15
CA2802176A1 (en) 2010-06-11 2011-12-15 The Board Of Regents, The University Of Texas System Methods of mitigating effects of radiation and reducing the risk of systemic infection
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
JP2022527136A (ja) * 2019-04-12 2022-05-30 アファームド ファーマ,エルエルシー 酢酸ルサラチド組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US6500934B1 (en) * 1996-07-24 2002-12-31 Michael Rush Lerner Bivalent agonists for G-protein coupled receptors
TWI257307B (en) 2000-07-12 2006-07-01 Orthologic Corp Pharmaceutical composition for cardiac tissue repair
WO2002005836A2 (en) 2000-07-19 2002-01-24 The Board Of Regents, The University Of Texas Systems Stimulation of bone growth with thrombin peptide derivatives
AU2001273561B2 (en) 2000-07-20 2004-10-28 Orthologic Corp. Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
JP4192093B2 (ja) 2001-07-27 2008-12-03 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 慢性皮膚潰瘍の治癒を促進する方法
TW200407905A (en) * 2002-11-06 2004-05-16 Leadtek Research Inc Data write-in and read-out method of flash memory and circuit thereof
CA2551525C (en) 2003-12-31 2013-02-19 David W. Hobson Pharmaceutical composition for thrombin peptide derivatives

Similar Documents

Publication Publication Date Title
JP2006507229A5 (enExample)
JP7649624B2 (ja) 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
JP2005053930A5 (enExample)
JP2004504354A5 (enExample)
CN1137898C (zh) 甲状旁腺素的类似物
EP1958957A1 (en) Polypeptide comprising a knottin protein moiety
UA89616C2 (ru) Гидролизат казеина, способ его получения и применения
JP4334480B2 (ja) α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
KR20110125235A (ko) 뉴로펩타이드 y 수용체 결합성 화합물을 포함하는 세포독성 접합체
JP2006514822A5 (enExample)
JP6811190B2 (ja) プロテアーゼ耐性脂質付加glp−1類似体
CA2301175C (en) Collagen mimics
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
JPWO2020120983A5 (enExample)
JP2012500284A (ja) ペプチド性pth受容体アゴニスト
JPH05502046A (ja) フィブロネクチン結合タンパク質
KR102520348B1 (ko) 페길화 생활성 펩타이드 및 그의 용도
KR20110125236A (ko) 하나 이상의 합성 아미노산 치환을 가지는 뉴로펩타이드 y 유사체
US7132394B2 (en) PTH-like peptides
ATE291033T1 (de) Therapeutische peptide
CA2719940A1 (en) Methods for treating acute myocardial infarction
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
Chorev et al. Biological activity of parathyroid hormone antagonists substituted at position 13
EP1632244A4 (en) PROPHYLACTICS OR REMEDIES FOR HEPATOPATHY